Fill-Finish 제조 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 제품별, 최종사용자별, 지역별 세분화 및 경쟁 구도(2020-2030년)
Fill-Finish Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End User, By Region and Competition, 2020-2030F
상품코드 : 1879278
리서치사 : TechSci Research
발행일 : 2025년 11월
페이지 정보 : 영문 180 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,500 ₩ 6,690,000
Unprintable PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 5,500 ₩ 8,176,000
PDF and Excel (Multi-User License) help
PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.
US $ 8,000 ₩ 11,893,000
PDF and Excel (Custom Research License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

세계의 Fill-Finish 제조 시장은 2024년에 174억 5,000만 달러로 평가되었고, 2030년까지 연평균 복합 성장률(CAGR) 9.41%로 성장하여 299억 3,000만 달러에 이를 것으로 예측됩니다.

충진 및 최종 포장 제조는 의약품 제조의 중요한 최종 단계로 약액을 바이알, 프리필드시린지, 카트리지 등의 최종 용기에 무균 상태로 이송한 후 엄격하게 관리된 무균 환경에서 밀봉 및 포장하여 제품의 무균성과 유효성을 확보하는 공정입니다. 이 시장의 성장은 주로 주사제 수요 증가, 특히 생물학적 제제 및 바이오시밀러의 보급 확대에 기인합니다. 이들은 특별한 무균 처리가 필요합니다. 또한, 신규 치료제 파이프라인의 확대와 제약회사들이 복잡하고 변화무쌍한 생산 수요를 관리하기 위해 위탁생산(CMO)을 전략적으로 도입하면서 시장 확대가 크게 촉진되고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 174억 5,000만 달러
시장 규모 : 2030년 299억 3,000만 달러
CAGR : 2025-2030년 9.41%
성장 속도가 가장 빠른 부문 소모품
최대 시장 유럽

주요 시장 성장 촉진요인

주요 시장 과제

주요 시장 동향

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 Fill-Finish 제조 시장 전망

제6장 북미의 Fill-Finish 제조 시장 전망

제7장 유럽의 Fill-Finish 제조 시장 전망

제8장 아시아태평양의 Fill-Finish 제조 시장 전망

제9장 중동 및 아프리카의 Fill-Finish 제조 시장 전망

제10장 남미의 Fill-Finish 제조 시장 전망

제11장 시장 역학

제12장 시장 동향과 발전

제13장 세계의 Fill-Finish 제조 시장 : SWOT 분석

제14장 Porter의 Five Forces 분석

제15장 경쟁 구도

제16장 전략적 제안

제17장 회사 소개 및 면책조항

LSH
영문 목차

영문목차

The Global Fill-Finish Manufacturing Market , valued at USD 17.45 Billion in 2024, is projected to experience a CAGR of 9.41% to reach USD 29.93 Billion by 2030. Fill-finish manufacturing represents the crucial final stage in pharmaceutical production, involving the aseptic transfer of drug formulations into their ultimate containment systems, such as vials, pre-filled syringes, or cartridges, followed by sealing and packaging under strictly controlled sterile conditions to ensure product sterility and efficacy. This market's growth is primarily driven by the increasing demand for injectable drugs, including a rising prevalence of biologics and biosimilars, which necessitate specialized aseptic processing. Additionally, the expanding pipeline of new therapies and the strategic adoption of contract manufacturing organizations by pharmaceutical companies to manage complex and variable production needs significantly propel market expansion.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 17.45 Billion
Market Size 2030USD 29.93 Billion
CAGR 2025-20309.41%
Fastest Growing SegmentConsumables
Largest MarketEurope

Key Market Drivers

The escalating demand for injectable drug products significantly influences the global fill-finish manufacturing market as an increasing number of advanced therapies, including biologics and vaccines, necessitate sterile parenteral administration. These complex drug formulations often require specialized handling and precise aseptic filling into vials, prefilled syringes, and cartridges. This growing need for injectable medicines mandates robust and high-capacity fill-finish operations to ensure product safety and efficacy. For instance, according to the WHO Global Vaccine Market Report, in 2024, India provided 84% of the vaccines procured in the Southeast Asia region and self-supplied 99% of its own procurements in 2023, underscoring the massive scale of injectable drug production and distribution. Simultaneously, the increased outsourcing to Contract Development and Manufacturing Organizations plays a pivotal role. Pharmaceutical companies frequently leverage CDMO expertise and infrastructure to manage the intricate technical challenges and capital investment associated with aseptic fill-finish processes, particularly for smaller batch personalized medicines or large-scale vaccine campaigns. Outsourcing allows pharmaceutical firms to focus on core research and development activities while ensuring specialized manufacturing capabilities are met.

Key Market Challenges

The substantial capital expenditure required for establishing and upgrading advanced aseptic fill-finish facilities poses a significant barrier to market expansion. Meeting stringent regulatory compliance standards necessitates considerable investment in advanced technologies, such as isolator systems and robotic aseptic lines. These infrastructures are essential to ensure the sterility and integrity of pharmaceutical products, particularly for complex biologic and biosimilar formulations.

This capital intensity directly hampers the market's growth by limiting the ability of manufacturers to invest in new capacity or modernize existing operations. Such high upfront costs can deter market entry and constrain expansion plans, thereby affecting the industry's agility in responding to evolving demands for both high-volume and specialized small-batch production.

Key Market Trends

Digitalization and artificial intelligence are transforming fill-finish manufacturing operations through enhanced efficiency and precision. These technologies enable real-time monitoring, predictive maintenance, and data-driven decision-making, vital for minimizing contamination and optimizing sterile processing. According to the 7th ISPE Pharma 4.0(TM) Survey conducted in 2023, organizations initiating digital operations dropped from 31.2% in 2021 to 15.1%, reflecting robust progression in adoption. The Parenteral Drug Association, in collaboration with the European Medicines Agency, utilizes artificial intelligence for quality control in advanced therapy medicinal products, enabling batch success prediction an hour in advance, as highlighted at the PDA Regulatory Conference in September 2025. This integration ensures agility and consistent product quality in parenteral drug manufacturing.

Key Market Players

Report Scope:

In this report, the Global Fill-Finish Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fill-Finish Manufacturing Market , By Product:

Fill-Finish Manufacturing Market , By End User:

Fill-Finish Manufacturing Market , By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Fill-Finish Manufacturing Market .

Available Customizations:

Global Fill-Finish Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Fill-Finish Manufacturing Market Outlook

6. North America Fill-Finish Manufacturing Market Outlook

7. Europe Fill-Finish Manufacturing Market Outlook

8. Asia Pacific Fill-Finish Manufacturing Market Outlook

9. Middle East & Africa Fill-Finish Manufacturing Market Outlook

10. South America Fill-Finish Manufacturing Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Fill-Finish Manufacturing Market : SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기